BRAF-mutated Tumors clinical trials at UCSF
1 in progress, 0 open to new patients
Sorry, in progress, not accepting new patients
The objective of this study is to determine the safety, pharmacokinetics, maximum tolerated dose/recommended Phase 2 dose, and efficacy of PLX8394.
San Francisco, California and other locations